Innovative Product Launches Sakura Finetek Europe continues to expand its product portfolio with recent launches such as the Tissue-Tek xPrint LP Laser Cassette Printer and the Tissue-Tek Genie staining system, indicating strong growth in advanced pathology solutions that can be leveraged to upsell or introduce complementary products.
Strategic Technology Integration The company's recent partnership to implement Oracle Cloud ERP and CX Applications demonstrates a focus on operational excellence and customer experience, providing opportunities to offer integrated digital solutions or customized support services to enhance client workflows.
Leadership and Market Focus Under the new leadership of President Jaap Stuut, Sakura is positioning itself for growth in pathology automation and tissue diagnostics, signaling a potential opening for targeted marketing of automation solutions and diagnostic systems to labs seeking to modernize their operations.
Regulatory and Industry Positioning With a clear focus on cancer diagnosis and pathology automation, Sakura presents an attractive proposition for healthcare providers and labs seeking cutting-edge, reliable diagnostic equipment, making it a strategic partner for expanding into oncology diagnostics.
Market and Revenue Scope Operating with a revenue range of $10 million to $25 million and a specialized niche in anatomic pathology, Sakura offers tailored solutions for midsize laboratories and healthcare institutions, highlighting opportunities for customized service packages and regional expansion strategies.
$1B$10B
$1B$10B
$10B
$250M$500M
$10B
$10B
$1B$10B
$10B
$1B$10BSakura Finetek Europe uses 8 technology products and services including Crazy Egg, Kentico, WordPress, and more. Explore Sakura Finetek Europe's tech stack below.
| Sakura Finetek Europe Email Formats | Percentage |
| FLast@sakuraus.com | 76% |
| First.Last@sakuraus.com | 18% |
| FMiddleLast@sakuraus.com | 2% |
| F.Last@sakuraus.com | 1% |
| LF@sakuraus.com | 1% |
| FirstL@sakuraus.com | 1% |
| Last@sakuraus.com | 1% |
| F.Last@sakura.eu | 93% |
| First.Last@sakura.eu | 3% |
| Last@sakura.eu | 3% |
| FLast@sakura.eu | 1% |
Medical Equipment ManufacturingSouth Holland, Netherlands201-500 Employees
Empowering pathologists and lab technicians worldwide. When it comes to diagnosing cancer, there’s no time to wait. At Sakura we’re driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. Our Mission: Advancing cancer diagnoses by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care.
Company Overview
Media & News
Funding & FinancialsSakura Finetek Europe's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsSakura Finetek Europe's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com